P53-dependent transcriptional regulation of EDA2R and its involvement in chemotherapy-induced hair loss

FEBS Letters

Volumn 584, Issue 11, 2010, Pages 2473-2477

  Brosh, Ran ^a   Sarig, Rachel ^a   Natan, Elad Bar ^a   Molchadsky, Alina ^a   Madar, Shalom ^a   Bornstein, Chamutal ^a   Buganim, Yosef ^a   Shapira, Tirosh ^a   Goldfinger, Naomi ^a   Paus, Ralf ^b,c   Rotter, Varda ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b UNIVERSITY OF LÜBECK   (Germany)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Alopecia; Chemotherapy induced alopecia; Cyclophosphamide; Knockout; XEDAR

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; PROTEIN P53; XEDAR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER TISSUE; CELL DEATH; CELL SURVIVAL; CELL TYPE; CONTROLLED STUDY; EMBRYO; ENZYME SPECIFICITY; FEMALE; HAIR LOSS; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; TRANSACTIVATION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

ALOPECIA; CELL DEATH; GENE EXPRESSION REGULATION; GENES, P53; TRANSCRIPTIONAL ACTIVATION; TUMOR SUPPRESSOR PROTEIN P53; XEDAR RECEPTOR;

EID: 77952955114     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2010.04.058     Document Type: Article

References (23)

1. Levine A.J., Oren M. The first 30 years of p53: growing ever more complex. Nat. Rev. Cancer 2009, 9:749-758.
2. Yan M., et al. Two-amino acid molecular switch in an epithelial morphogen that regulates binding to two distinct receptors. Science 2000, 290:523-527.
3. Visinoni A.F., Lisboa-Costa T., Pagnan N.A., Chautard-Freire-Maia E.A. Ectodermal dysplasias: clinical and molecular review. Am. J. Med. Genet. A 2009, 149A:1980-2002.
4. Sinha S.K., Chaudhary P.M. Induction of apoptosis by X-linked ectodermal dysplasia receptor via a caspase 8-dependent mechanism. J. Biol. Chem. 2004, 279:41873-41881.
5. Chang B., Punj V., Shindo M., Chaudhary P.M. Adenoviral-mediated gene transfer of ectodysplasin-A2 results in induction of apoptosis and cell-cycle arrest in osteosarcoma cell lines. Cancer Gene Ther. 2007, 14:927-933.
6. Drew C.F., Lin C.M., Jiang T.X., Blunt G., Mou C., Chuong C.M., Headon D.J. The Edar subfamily in feather placode formation. Dev. Biol. 2007, 305:232-245.
7. Prodi D.A., et al. EDA2R Is Associated with Androgenetic Alopecia. J. Invest. Dermatol. 2008, 128:2268-2270.
8. Newton K., French D.M., Yan M., Frantz G.D., Dixit V.M. Myodegeneration in EDA-A2 transgenic mice is prevented by XEDAR deficiency. Mol. Cell Biol. 2004, 24:1608-1613.
9. Tanikawa C., Furukawa Y., Yoshida N., Arakawa H., Nakamura Y., Matsuda K. XEDAR as a putative colorectal tumor suppressor that mediates p53-regulated anoikis pathway. Oncogene 2009, 28:3081-3092.
10. Botchkarev V.A., Komarova E.A., Siebenhaar F., Botchkareva N.V., Komarov P.G., Maurer M., Gilchrest B.A., Gudkov A.V. p53 is essential for chemotherapy-induced hair loss. Cancer Res. 2000, 60:5002-5006.
11. Botchkarev V.A. Molecular mechanisms of chemotherapy-induced hair loss. J. Invest. Dermatol. Symp. Proc. 2003, 8:72-75.
12. Trueb R.M. Chemotherapy-induced alopecia. Semin. Cutan. Med. Surg. 2009, 28:11-14.
13. Berkovich E., Ginsberg D. ATM is a target for positive regulation by E2F-1. Oncogene 2003, 22:161-167.
14. Milyavsky M., et al. Prolonged culture of telomerase-immortalized human fibroblasts leads to a premalignant phenotype. Cancer Res. 2003, 63:7147-7157.
15. Paus R., Handjiski B., Eichmuller S., Czarnetzki B.M. Chemotherapy-induced alopecia in mice. Induction by cyclophosphamide, inhibition by cyclosporine A, and modulation by dexamethasone. Am. J. Pathol. 1994, 144:719-734.
16. Vassilev L.T., et al. In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 2004, 303:844-848.
17. Botchkarev V.A., et al. p53 Involvement in the control of murine hair follicle regression. Am. J. Pathol. 2001, 158:1913-1919.
18. el-Deiry W.S., et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993, 75:817-825.
19. Bodo E., Tobin D.J., Kamenisch Y., Biro T., Berneburg M., Funk W., Paus R. Dissecting the impact of chemotherapy on the human hair follicle: a pragmatic in vitro assay for studying the pathogenesis and potential management of hair follicle dystrophy. Am. J. Pathol. 2007, 171:1153-1167.
20. Sharov A.A., Siebenhaar F., Sharova T.Y., Botchkareva N.V., Gilchrest B.A., Botchkarev V.A. Fas signaling is involved in the control of hair follicle response to chemotherapy. Cancer Res. 2004, 64:6266-6270.
21. Chipuk J.E., Green D.R. Dissecting p53-dependent apoptosis. Cell Death Differ. 2006, 13:994-1002.
22. Jacobs W.B., Kaplan D.R., Miller F.D. The p53 family in nervous system development and disease. J. Neurochem. 2006, 97:1571-1584.
23. Sinha S.K., Zachariah S., Quinones H.I., Shindo M., Chaudhary P.M. Role of TRAF3 and -6 in the activation of the NF-kappa B and JNK pathways by X-linked ectodermal dysplasia receptor. J. Biol. Chem. 2002, 277:44953-44961.